INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

74,735 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
April McClain DelaneyDDependent child
TRMBTRIMBLE INC.
Sale
SELL$100K – $250KAug 25, 2026
Page 465 of 1869
← PrevNext →
Sep 9, 2026
traded Aug 25, 2026
+15d
House PTR

Evidence

30
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$793K
17.9K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$195K
504 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

30
Cory A. BookerDSpouse
WCwebAI, Inc. Company: webAI, Inc. (Austin, TX) Description: Technology Company
Sale (Full)
SELL$50K – $100KAug 18, 2026Sep 9, 2026
traded Aug 18, 2026
+22dSenate PTR

Evidence

30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$90K
233 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

29
Cory A. BookerDSpouse
MCDMCDONALDS CORP
Sale (Full)
SELL$15K – $50KAug 11, 2026Sep 9, 2026
traded Aug 11, 2026
+29dSenate PTR

Evidence

29
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,368
65 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

29
MA
Merriman AndrewChief Operating Officer
CTMCastellum, Inc.
Open-market purchase
BUY$25K
40.0K sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

29
Maria Elvira SalazarRSelf
BRK.BBerkshire Hathaway Inc. New Common Stock
Purchase
BUY$1,001 – $15KAug 7, 2026Sep 9, 2026
traded Aug 7, 2026
+33dHouse PTR

Evidence

29
CG
Crook Nathaniel GlennChief Commercial Officer
AMPLAmplitude, Inc.
Open-market sale · 10b5-1 plan
SELL$3.90M
300.0K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$1.41M
16.1K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
Maria Elvira SalazarRSelf
MRKMerck & Co., Inc.
Purchase
BUY$15K – $50KAug 19, 2026Sep 9, 2026
traded Aug 19, 2026
+21dHouse PTR

Evidence

28
Maria Elvira SalazarRSelf
MRKMerck & Co., Inc.
Purchase
BUY$15K – $50KAug 19, 2026Sep 9, 2026
traded Aug 19, 2026
+21dHouse PTR

Evidence

28
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$135K
1,590 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
MN
Meriweather Tiffany N.Chief Admin. & Legal Officer
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$262K
7,809 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$24
2 sh
Sep 2, 2026Sep 9, 2026
traded Sep 2, 2026
+7dSEC Form 4

Evidence

28
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$190K
4,500 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

28
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$96
8 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$1.30M
14.4K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$24
2 sh
Sep 3, 2026Sep 9, 2026
traded Sep 3, 2026
+6dSEC Form 4

Evidence

28
April McClain DelaneyDDependent child
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

27
ES
Evran SedatEVP, Global Supply Chain
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
864 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
April McClain DelaneyDDependent child
CPAYCORPAY, INC.
Partial sale
SELL$1,001 – $15KAug 3, 2026Sep 9, 2026
traded Aug 3, 2026
+37dHouse PTR

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
1,370 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
MM
Mulshine Brendan MartinCo-President and CRO
RYANRYAN SPECIALTY HOLDINGS, INC.
Derivative conversion
C—
40.0K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
1,370 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
456 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
AS
Allison SchwartzDirector
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
92 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
Maria Elvira SalazarRSelf
QCOMQUALCOMM INC/DE
Sale
SELL$1,001 – $15KAug 12, 2026Sep 9, 2026
traded Aug 12, 2026
+28dHouse PTR

Evidence

27
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$388K
4,564 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
SA
Stepak AvnerDirector
ETOReToro Group Ltd.
Derivative conversion
C—
33.8K sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
685 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
CD
Collins John DeNeenChief Financial Officer
SOUNSOUNDHOUND AI, INC.
Grant or award
A—
1.00M sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
768 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$735K
12.9K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
768 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
RG
Ramdas GautamPresident and CEO
NTICNORTHERN TECHNOLOGIES INTERNATIONAL CORP
Grant or award
A—
43.8K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
685 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

26
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$118K
305 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

26
April McClain DelaneyDDependent child
PAYXPAYCHEX INC
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence